https://doi.org/10.1038/s41375-021-01466-0
N
Nicolaus Kröger
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
1.8K
Citations
23
h-index
40
i10-index
Nicolaus Kröger is an academic researcher from Universität Hamburg. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Hematopoietic Stem Cell Transplantation & Chronic Myeloid Leukemia Treatments. The author has an h-index of 23, co-authored 133 publications.
Papers by this author
worksPoor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
2021 · Leukemia · 113 citations
Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
2024 · Blood Cancer Journal · 19 citations
https://doi.org/10.1038/s41408-024-01197-2
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the <scp>EBMT</scp>
2022 · American Journal of Hematology · 18 citations
https://doi.org/10.1002/ajh.26764
The first steps towards a diverse and inclusive EBMT: a position paper
2022 · Bone Marrow Transplantation · 5 citations
https://doi.org/10.1038/s41409-022-01586-w
Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the <scp>European Society for Blood and Marrow Transplantation</scp>
2023 · American Journal of Hematology · 5 citations
https://doi.org/10.1002/ajh.26825
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
2022 · Bone Marrow Transplantation · 4 citations
https://doi.org/10.1038/s41409-021-01555-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat